Venetoclax in AML: Where We Are and Where We Are Headed
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology,Hematology
Reference12 articles.
1. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel;Dohner;Blood,2017
2. Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia;DiNardo;Blood,2018
3. Outcomes of older patients with NPM1-mutated AML: current treatments and the promise of venetoclax-based regimens;Lachowiez;Blood Advances,2020
4. Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia;Pollyea;Nat Med,2018
5. Inhibition of amino acid metabolism selectively targets human leukemia stem cells;Jones;Cancer Cell,2018
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Invasive fungal infection following venetoclax and posaconazole co‐administration;British Journal of Haematology;2023-09-20
2. Mitophagy Promotes Resistance to BH3 Mimetics in Acute Myeloid Leukemia;Cancer Discovery;2023-04-24
3. Higher-dose venetoclax with measurable residual disease-guided azacitidine discontinuation in newly diagnosed acute myeloid leukemia;Haematologica;2023-04-13
4. Venetoclax in Acute Myeloid Leukemia;Recent Patents on Anti-Cancer Drug Discovery;2023-02
5. AVALON: The Italian cohort study on real‐life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia;Cancer;2023-01-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3